NewsNovo
Benzinga published a list of six biotech penny stocks, identifying Evelo Biosciences, Vivo Therapeutics, Molecular Templates Vaccinex, Sonnet BioTherapeutics Holdings, Minerva Surgical, and Precigen as potential investment opportunities.
The article by Chris Davis frames this selection against a backdrop of intense market speculation driven by the COVID-19 pandemic, noting that investors are actively seeking profits in the sector despite the high risks associated with low-priced shares.
The publication argues that the current climate mirrors the rapid growth seen in the 1990s internet boom, suggesting that the next major industry leader could emerge from biotechnology.
Davis points to large-cap firms like Novavax, Co-Diagnostics, Inovio, Moderna, Pfizer, and Johnson & Johnson as examples of companies that capitalized on media attention and clinical trial updates.
Keep reading